FameLifter LogoFameLifter
Top ChannelsSearchCompareTrendingStatisticsPricing

Top YouTube Channels by Country

United StatesUnited KingdomIndiaBrazilTurkeyGermanyFranceMexicoJapanSouth KoreaSpainItalyCanadaAustraliaRussiaIndonesiaPolandNetherlandsSwedenArgentina
FameLifter LogoFameLifter

Advanced YouTube analytics platform helping creators and businesses understand their performance and grow their audience.

Product

  • Channel Analytics
  • Top Channels
  • Blog
  • Features
  • Video Comparison

Company

  • About Us
  • Contact
  • Help Center
  • What's New
  • Privacy Policy
  • Terms of Service
  • Cookie Policy

© 2026 FameLifter. All rights reserved.

MAITHINK X

MAITHINK X

DE
@maithinkx
242
Video Count
165.4M
Video View
1.5M
Subscriber
#399
Germany Rank
#37,582
Global Rank
242
Video Count
165.4M
Video View
1.5M
Subscriber
#399
Germany Rank
#37,582
Global Rank
  1. Home
  2. Channel Analytics
  3. MAITHINK X
MAITHINK X YouTube channel subscribers:1,520,000- Seelive statisticsand growth insights below.
OverviewVideosOutliersStatisticsSimilar ChannelsTimelineRetention AnalyticsAbout

MAITHINK X YouTube Statistics & Analytics

Subscribers
1.5M
Total Views
165.4M
Videos
242
Activity
Unknown

MAITHINK X Content Analysis

Content Type Distribution

Long videosLong
89%
212 videos
ShortsShorts
11%
27 videos

📽️ This channel specializes in long-form videos. Deep dives and comprehensive content perform well here.

Content Categories

Primary CategoryScience & Technology
71%
Science & Technology
169(71%)
People & Blogs
49(21%)
Film & Animation
10(4%)
Howto & Style
5(2%)
Education
4(2%)
Entertainment
2(1%)

🎯 Primary focus: Science & Technology with 169 videos (71% of categorized content).

MAITHINK X AI Channel Analysis

Gemini ProScore: 7.2/10

AI-powered insights analyzing content strategy, audience engagement, and growth potential.

Overall Score
7.2
Consistency
95%
Cadence
2-3/wk
Library
50

Growth Potential

7.5/10

Good content foundation. Increasing upload frequency could boost growth.

Audience Engagement

7.2/10

Moderate engagement levels. Focus on community interaction could improve metrics.

Content Strategy

7/10

Developing content strategy. Consider focusing on specific niches for better targeting.

AI Recommendations

Auto-prioritized by predicted impact

  1. 1
    Increase upload frequency to 2-3 videos per week
    High ImpactCadence
  2. 2
    Focus on SEO optimization for better discoverability
    High ImpactSEO
  3. 3
    Analyze top-performing content for pattern replication
    MediumStrategy
  4. 4
    Increase community engagement through comments and polls
    MediumEngagement

Latest Video

Long video
Keine Kraft mehr
26:46

Keine Kraft mehr

539.9K
Views
21.8K
Likes
2 weeks ago
Published

Dieses Video und den Xperts Talk zum Thema ME/CFS gibt es auch reizarm als Podcast – überall, wo es Podcasts gibt. MEHR MAITHINK X ► Xperts Talk zu ME/CFS: https://maithinkx.de/xperts_mecfs 🆕 Neue Folge: Wie sicher ist unser Wasser wirklich? https://maithinkx.de/wasser ► Alle Folgen MAITHINK X - Die Show: https://maithinkx.de/alle-folgen ► Instagram: https://instagram.com/maithinkx ► TikTok: https://www.tiktok.com/@maithinkx ► YouTube-Kanal abonnieren: https://maithinkx.de/abo KAPITEL 00:00 Intro 01:53 Was ist ME/CFS? 06:37 Symptome & Diagnose 14:01 PEM & Pacing 18:49 Hürden bei Ärzten und Behörden 19:57 Was löst ME/CFS aus? 21:12 Behandlungsmöglichkeiten 24:09 Post-Vac & Infektionsschutz Netiquette: https://kurz.zdf.de/MAINetti Eine Produktion von Dr. Mai Thi Nguyen-Kim und der bildundtonfabrik für ZDFneo. Impressum: https://kurz.zdf.de/MAImpres QUELLEN Appleman et al. (2024), Nat Commun https://doi.org/10.1038/s41467-023-44432-3 BMFTR (13.11.2025) https://www.bmftr.bund.de/SharedDocs/Kurzmeldungen/DE/2025/11/nationale-dekade-postinfektiöse-erkrankungen.html BMG (2024) https://www.bmg-longcovid.de/infobox/wissenswertes-fuer-erkrankte-und-interessierte Chang et al. (2023), J Transl Med https://doi.org/10.1186/s12967-023-04636-z Charlton et al. (2025), MedrXiv https://doi.org/10.1101/2025.05.02.25326885 Charlton et al. (2025), Trends Endcrinol Metab https://10.1016/j.tem.2024.11.008 Cleveland Clinic (19.06.2023) https://my.clevelandclinic.org/health/diseases/25111-long-covid Daniell et al. (2025), ME/CFS Research Foundation https://mecfs-research.org/wp-content/uploads/2025/05/The-rising-cost-of-Long-COVID-and-MECFS-in-Germany.pdf Eckey et al. (2025), PNAS https://doi.org/10.1073/pnas.2426874122open_in_new Habermann-Horstmeier & Horstmeier (2024), Prävention und Gesundheitsförderung https://doi.org/10.1007/s11553-023-01070-3 Haunhorst et al. (2024), Infection https://doi.org/10.1007/s15010-024-02386-8 Hosseini & Askari (2023), Eur J Med Res https://doi.org/10.1186/s40001-023-00992-0 ​​Jonsjö et al. (2020), Psychoneuroendocrinology https://doi.org/10.1016/j.psyneuen.2019.104578 Kassenärztliche Bundesvereinigung (2025) https://www.kbv.de/documents/praxis/tools-und-services/qz/long-covid/qualitaetszirkel-long-covid.pdf Komaroff & Dantzer (2025), Cell Rep Med https://doi.org/10.1016/j.xcrm.2025.102259 Maes et al. (2013), Expert Opin Med Diagn https://doi.org/10.1517/17530059.2013.776039 Morita et al. (2024), PLOS ONE https://doi.org/10.1371/journal.pone.0315385 Nielson et al. (2001), Pain https://doi.org/10.1016/S0304-3959(00)00351-1 Nunes et al. (2026), Cell Death Dis https://doi.org/10.1038/s41419-025-08162-2 O'Regan et al. (2024), NPJ Vaccines https://www.nature.com/articles/s41541-024-00844-w Paul-Ehrlich-Institut (2023), Bulletin zur Arzneimittelsicherheit https://www.pei.de/SharedDocs/Downloads/DE/newsroom/bulletin-arzneimittelsicherheit/2023/2-2023.pdf Peter et al. (2025), PLOS Medicine https://doi.org/10.1371/journal.pmed.1004511 Picard et al. (2012), Am J Physiol Cell Physiol https://doi.org/10.1152/ajpcell.00368.2011 Renz-Polster et al. (2022), Pädiatrie https://doi.org/10.1007/s15014-022-4043-z Thomas et al. (2022), Front Neuroendocrinol https://doi.org/10.1016/j.yfrne.2022.100995 Scheibenbogen & Wirth (2025), J Cachexia Sarcopenia Muscle https://doi.org/10.1002/jcsm.13669Digital Object Identifier (DOI) Sotzny et al. (2018), Autoimmun Rev https://doi.org/10.1016/j.autrev.2018.01.009 Syed et al. (2025), Physiology https://doi.org/10.1152/physiol.00056.2024 Vernon et al. (2025), J Gen Intern Med https://doi.org/10.1007/s11606-024-09290-9 WHO (26.02.2025) https://www.who.int/news-room/fact-sheets/detail/post-covid-19-condition-(long-covid)

Mai maiLab Lab

Top 5 Videos

#1
Die unangenehme Wahrheit hinter Rassentheorie

Die unangenehme Wahrheit hinter Rassentheorie

1.3M
Sep 15, 2024
#2
Wenn Amerika kippt | Eine Analyse

Wenn Amerika kippt | Eine Analyse

1M
Oct 29, 2024
#3
Ihr seid dumm.

Ihr seid dumm.

875.7K
Nov 8, 2024
#4
Volker Wissing EXPOSED

Volker Wissing EXPOSED

822.9K
Aug 9, 2024
#5
Protein-Hype wissenschaftlich geprüft

Protein-Hype wissenschaftlich geprüft

790.7K
6 months ago

MAITHINK X AI Channel Analysis

Gemini ProScore: 7.2/10

AI-powered insights analyzing content strategy, audience engagement, and growth potential.

Overall Score
7.2
Consistency
95%
Cadence
2-3/wk
Library
50

Growth Potential

7.5/10

Good content foundation. Increasing upload frequency could boost growth.

Audience Engagement

7.2/10

Moderate engagement levels. Focus on community interaction could improve metrics.

Content Strategy

7/10

Developing content strategy. Consider focusing on specific niches for better targeting.

AI Recommendations

Auto-prioritized by predicted impact

  1. 1
    Increase upload frequency to 2-3 videos per week
    High ImpactCadence
  2. 2
    Focus on SEO optimization for better discoverability
    High ImpactSEO
  3. 3
    Analyze top-performing content for pattern replication
    MediumStrategy
  4. 4
    Increase community engagement through comments and polls
    MediumEngagement

Frequently Asked Questions About MAITHINK X

Data Source & Accuracy

Source: YouTube Data API v3
Accuracy: Real-time statistics from official YouTube API
Data is updated hourly and sourced directly from official APIs to ensure accuracy and reliability.

Data from YouTube Data API v3 • Updated hourly • Last updated: 05:16 AM